LifeMD Inc LFMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LFMD is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $12.49
- Day Range
- $12.25–12.80
- 52-Week Range
- $1.46–12.80
- Bid/Ask
- $12.25 / $12.60
- Market Cap
- $489.00 Mil
- Volume/Avg
- 870,408 / 654,636
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.78
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 232
- Website
- https://www.lifemd.com
Comparables
Valuation
Metric
|
LFMD
|
OPRX
|
CMAX
|
---|---|---|---|
Price/Earnings (Normalized) | — | 46.64 | — |
Price/Book Value | 136.53 | 1.52 | 0.20 |
Price/Sales | 2.78 | 2.54 | 0.02 |
Price/Cash Flow | 108.40 | 21.89 | — |
Price/Earnings
LFMD
OPRX
CMAX
Financial Strength
Metric
|
LFMD
|
OPRX
|
CMAX
|
---|---|---|---|
Quick Ratio | 1.10 | 10.96 | 0.41 |
Current Ratio | 1.22 | 11.35 | 0.42 |
Interest Coverage | −5.71 | — | −11.57 |
Quick Ratio
LFMD
OPRX
CMAX
Profitability
Metric
|
LFMD
|
OPRX
|
CMAX
|
---|---|---|---|
Return on Assets (Normalized) | −18.78% | 3.18% | −14.63% |
Return on Equity (Normalized) | — | 3.64% | −31.50% |
Return on Invested Capital (Normalized) | −58.73% | 3.03% | −10.43% |
Return on Assets
LFMD
OPRX
CMAX
Health Information Services Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Fnwrng | $36.3 Bil | |
VEEV
| Veeva Systems Inc Class A | Mpvtyhvzcd | Vxxd | $32.9 Bil | |
SOLV
| Solventum Corp | — | Rrbbp | $11.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Djlmjvd | $7.8 Bil | |
MTHRF
| M3 Inc | — | Ghnnry | $7.3 Bil | |
MTHRY
| M3 Inc ADR | — | Rttszj | $7.3 Bil | |
HQY
| HealthEquity Inc | — | Xrqgt | $6.8 Bil | |
RCM
| R1 RCM Inc | — | Hbjlw | $5.2 Bil | |
DOCS
| Doximity Inc Class A | — | Lvrqw | $4.5 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Nljmx | $3.3 Bil |